Patients should contact their GP or healthcare provider urgently if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Difficulty swallowing or painful swallowing Unexplained weight loss Vomiting blood or passing black stools (seek immediate emergency care) Note that the 3 mg dose of Rybelsus is only for treatment initiation (30 days), and dose escalation to 7 mg (and later 14 mg if needed) can be delayed if gastrointestinal side effects persist
Many patients who previously used Ozempic for weight loss switch to Tirzepatide for faster and more effective results
It is not medical advice, not a treatment recommendation, and not intended to diagnose, treat, cure, or prevent disease
As gastrointestinal cancer outcomes were secondary or exploratory endpoints in the majority of included trials, these analyses are inherently vulnerable to type I error, outcome misclassification, and inadequate statistical power